← back to search

Katherine A. White

Sanford Research · US
Area of research
Research interest
Research topics from publications: A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes; NF1+/ex42del miniswine model the cellular disruptions and behavioral presentations of NF1-associated cognitive and motor impairment. Representative work: Mouse models of CLN3 Batten disease, a rare lysosomal storage disorder with no cure, have improved our understanding of CLN3 biology and therapeutics through their ease of use and a consistent display of cellular pathology. However, the translatability of murine models is limited by disparities in anatomy, body size, life span and inconsistent subtle behavior deficits that can be difficult to detect in CLN3 mutant mouse models, thereby limiting their use in preclinical studies. Here, we present a longitudinal characterization of a novel miniswine model of CLN3 disease that recapitulates the most common human pathogenic variant, an exon 7-8 deletion (CLN3Δex7/8). Progressive pathology and neu Cognitive or motor impairment is common among individuals with neurofibromatosis type 1 (NF1), an autosomal dominant tumor-predisposition disorder. As many as 70% of children with NF1 report difficulties with spatial/working memory, attention, executive function, and fine motor movements. In contrast to the utilization of various Nf1 mouse models, here we employ an NF1+/ex42del miniswine model to evaluate the mechanisms and characteristics of these presentations, taking advantage of a large animal species more like human anatomy and physiology. The prefrontal lobe, anterior cingulate, and hippocampus from NF1+/ex42del and wild-type miniswine were examined longitudinally, revealing abnormalit
h-index
citations
12
works
2
NIH funding
primary concept
email

Recent publications

NF1<sup>+/ex42del</sup> miniswine model the cellular disruptions and behavioral presentations of NF1-associated cognitive and motor impairment.
2024cited by 3position: middledoi
A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes.
2023cited by 9position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tyler B. Johnson · Black Hills State University2 papers (2023–2024)Jill M. Weimer · Sanford Research2 papers (2023–2024)Vicki J. Swier · Sanford Research2 papers (2023–2024)Christopher S. Rogers · Exemplar Genetics (United States)1 papers (2024–2024)Jon J. Brudvig · University of South Dakota1 papers (2023–2023)Ruchira Singh · University of Rochester1 papers (2023–2023)Mitchell J. Rechtzigel · Sanford Research1 papers (2024–2024)Hannah G. Leppert · Lewis University1 papers (2024–2024)Rajesh Khanna · Indiana University School of Medicine1 papers (2024–2024) · 1 papers (2024–2024)Pedro L. Negrão de Assis · Sanford Health1 papers (2024–2024)David K. Meyerholz · University of Iowa Holden Comprehensive Cancer Center1 papers (2024–2024)Jimin Han · 1 papers (2023–2023)Rebecca D. Dodd · Univeristy of Iowa1 papers (2024–2024)Dawn E. Quelle · National Institute of Neurological Disorders and Stroke1 papers (2024–2024)David A. Pearce · University of South Dakota1 papers (2023–2023)